SCNI Scinai Immunotherapeutics Ltd.

NASDAQ
$1.55

Scinai Immunotherapeutics Ltd. (SCNI) SEC Filings

Everything SCNI has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

6 filings
Date Form Filing
6-K Delisting
6-K Material Agreement · Other Reg Fd · Restructuring
6-K Acquisition Disposition · Capital Raise · Earnings Release · Guidance Update · Investor Presentation · Material Agreement · Other · Restructuring
6-K Delisting
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.